pyrroles has been researched along with c-peptide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, I; Blacker, C; Cesselin, F; Chalon, S; Fuseau, E; Landault, C; Puech, AJ; Rosenzweig, P | 1 |
| Geiss, HC; Huptas, S; Otto, C; Parhofer, KG | 1 |
| Eriksson, M; Gustafsson, U; Parini, P; Pramfalk, C; Sahlin, S | 1 |
| Heinemann, L; Heise, T; Herder, C; Koenig, W; Kolb, H; Martin, S; Schloot, NC | 1 |
| Berkova, Z; Koblas, T; Leontovyč, I; Pektorova, L; Saudek, F; Zacharovova, K | 1 |
| Heinemann, L; Heise, T; Herder, C; Koenig, W; Kolb, H; Martin, S; Roden, M; Schloot, NC; Simon, MC; Strom, A | 1 |
| Bartko, J; De Vries, F; Derhaschnig, U; Harcken, C; Jilma, B; Leuschner, J; Nabozny, GH; Neels, T | 1 |
5 trial(s) available for pyrroles and c-peptide
| Article | Year |
|---|---|
Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Glipizide; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Indoles; Insulin; Male; Pyrroles; Reference Values | 1994 |
Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
Topics: Adult; Atorvastatin; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Pyrroles; Treatment Outcome | 2006 |
Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism.
Topics: Adult; Aged; Atorvastatin; Blood Glucose; C-Peptide; Carbohydrates; Drug Administration Schedule; Female; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Lipids; Liver; Male; Middle Aged; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Triglycerides | 2011 |
Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial.
Topics: Adult; Atorvastatin; C-Peptide; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Insulin-Secreting Cells; Lipids; Male; Pyrroles; Treatment Outcome | 2011 |
Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).
Topics: Adolescent; Adult; Age of Onset; Atorvastatin; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 1; Female; Germany; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin-Secreting Cells; Male; Pyrroles; Young Adult | 2012 |
2 other study(ies) available for pyrroles and c-peptide
| Article | Year |
|---|---|
The effect of epigenetic factors on differentiation of pancreatic progenitor cells into insulin-producing cells.
Topics: Azacitidine; Azepines; C-Peptide; Cell Culture Techniques; Cell Differentiation; Decitabine; Epigenesis, Genetic; Humans; Hydroxamic Acids; Immunohistochemistry; Insulin-Secreting Cells; Islets of Langerhans; Keratin-19; Models, Biological; Models, Genetic; Pancreas; Pyrroles; Quinazolines; Stem Cells; Transcription Factors | 2011 |
Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Bone and Bones; C-Peptide; Cytokines; Disease Models, Animal; Dogs; Endotoxemia; Insulin; Male; Osteocalcin; Pyridines; Pyrimidines; Pyrroles; Receptors, Glucocorticoid | 2017 |